CD-NP
CD-NP is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients
Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
CD-NP in Subjects With Stable Chronic Heart Failure
Clinical Trials (8)
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients
Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
CD-NP in Subjects With Stable Chronic Heart Failure
Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure
Safety Study of CD-NP in Heart Failure
Safety and Pharmacodynamic Study of CD-NP
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8